The CE mark is the first regulatory approval received for Cerus ... associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more ...
The CE mark is the first regulatory approval received ... associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback